Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study

Andrea Biondi, Martin Schrappe, Paola De Lorenzo, Anders Castor, Giovanna Lucchini, Virginie Gandemer, Rob Pieters, Jan Stary, Gabriele Escherich, Myriam Campbell, Chi-Kong Li, Ajay Vora, Maurizio Arico, Silja Roettgers, Vaskar Saha, Maria Grazia Valsecchi

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science